Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.

U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib)  On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society

Resources from Leukemia & Lymphoma Society

A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Accelerate the Cure News

Accelerate the Cure News

Accelerate the Cure is much more than a campaign slogan. It’s our next 31 million USD effort, over five years, to find a cure and support those with WM and their caregivers. Global researchers have a new set of WM research targets, and they are afire with excitement....
2024 Walk for Waldenstrom’s Launches

2024 Walk for Waldenstrom’s Launches

Now that the 2024 Walk for Waldenstrom’s has officially launched, we’re lacing up our shoes, starting fundraisers, and spreading the word that we will find a cure. Every year, during Blood Cancer Awareness Month, September 2024, we come together to show our...
August Is National Make-A-Will Month

August Is National Make-A-Will Month

Did you know August is National Make-A-Will Month? By creating your will this month, you can get peace of mind for the future, protect your family, and support the future of the IWMF. Nearly 67% of American adults don’t have a will, and we’re sharing a free,...
IWMF ANNOUNCES 2024 RESEARCH GRANT RECIPIENTS

IWMF ANNOUNCES 2024 RESEARCH GRANT RECIPIENTS

IWMF has committed to the biggest package of research since its inception. Our vision—A world without WM—is finally within reach as summarized by Dr. Steven Treon, of Dana-Farber Cancer Institute, “Once we do a better job at shutting down the signaling of that...
Patient Advocacy at New BeiGene Facility

Patient Advocacy at New BeiGene Facility

Patient Advocacy at New BeiGene Facility Newton Guerin, IWMF President & CEO, joined leaders of patient advocacy organizations throughout the U.S. to celebrate the grand opening of BeiGene’s flagship U.S. Biologics Manufacturing and Clinical R&D facility in...
IWMF Issues New Request for Proposals  to Global WM Researchers

IWMF Issues New Request for Proposals to Global WM Researchers

On July 17th,The latest Request for Proposals (RFP) was sent to nearly 300 WM researchers around the world. The RFP is a result of the ongoing collaborative endeavor between the IWMF and LLS that began in 2015 with the development of the IWMF-LLS Strategic Research...
Active Monitoring

Active Monitoring

By Kat Tucker, WMUK Earlier this spring, WMUK was proud to launch the Active Monitoring Checklist—a resource to help both patients and healthcare professionals navigate conversations around Active Monitoring (AM) and improve care during this period of time for people...
Medical News Roundup

Medical News Roundup

By Sue Herms, IWMF Research Committee Member Long-Term Results Published from French Clinical Trial of Bendamustine and Rituximab Therapy in Treatment Naïve WM – The British Journal of Haematology has published an update with long-term results from the 2013- 2017...